Atos opens Life Sciences Centre of Excellence to accelerate drug development and enable precision health solutions
30 Juin 2022 - 10:00AM
Atos opens Life Sciences Centre of Excellence to accelerate drug
development and enable precision health solutions
Paris,
30 June, 2022 -
Atos, in agreement with the Wellcome Genome Campus in
Cambridgeshire, UK, today announces the official opening of its
global Life Sciences Centre of Excellence. The facility will
provide scientists on campus, and global genome and bio-data
institutes worldwide, early access to emerging technologies to
support their research, helping to accelerate the process of
bringing new drugs to market and delivering tangible societal
benefits.
The Atos Life Sciences Centre of Excellence is
an exploration, discovery and co-creation instrument aimed at
complementing the existing Campus compute facilities with access to
leading-edge technologies, such as Quantum, High-Performance
Computing, Edge Computing and AI, supported by Atos’ products,
services and expertise in these sectors. The facility will also
feature leading-edge technologies from Atos partners including Arm,
Intel, and NetApp. First established during the Covid-19
confinement crisis, this center provided support to researchers
worldwide studying many different aspects of the
virus. Atos experts world-wide will collaborate directly
with genome and biological data research scientists to help
transform ideas into reality, focusing specifically on enabling the
implementation of precision health and accelerating drug
development using digital technologies. The aim is to create
solutions that enable healthcare organisations to design efficient
strategies to prevent and manage disease and to support
pharma/biotech and medtech organisations in in accelerating the
development of targeted treatments/cutting edge medical equipment
and sensors, helping to tackle the greatest health challenges in
society today.
The outcomes from collaboration between Atos and
health and life sciences stakeholders will be showcased at the
Centre of Excellence through innovation workshops, proof-of-concept
production, demos and webinars.
Dr Natalia Jimenez, Global Life Sciences
Product Lead, Atos said: “The opening of
the Life Sciences Centre of Excellence is a significant milestone
in Atos’ pioneering work to drive innovation in the healthcare and
life sciences industry. By providing an ecosystem where genome and
biological data research scientists can access emerging
technologies accompanied by leading Atos experts, the Centre of
Excellence will play a crucial role in fostering life sciences
discovery and innovation, expediting the time it takes to bring new
drugs to market and delivering tangible benefits to
patients.”
Dr Julia Wilson,
Associate Director, Wellcome
Sanger Institute commented: “We are delighted that Atos
has joined our Campus community, and look forward to partnering
with them to maximise the vast range of opportunities the Centre of
Excellence will provide for scientists here and worldwide. Emerging
technologies such as Quantum, High-Performance Computing, Edge
Computing and AI hold transformative potential for advancing
biodata research, helping the life sciences sector to shorten the
drug development process and reduce costs.”
***
About Atos
Atos is a global leader in digital
transformation with 111,000 employees and annual revenue of c. € 11
billion. European number one in cybersecurity, cloud and
high-performance computing, the Group provides tailored end-to-end
solutions for all industries in 71 countries. A pioneer in
decarbonization services and products, Atos is committed to a
secure and decarbonized digital for its clients. Atos is a SE
(Societas Europaea), listed on Euronext Paris and included in the
CAC 40 ESG and Next 20 Paris Stock indexes.
The purpose of Atos is to help design the future
of the information space. Its expertise and services support the
development of knowledge, education and research in a multicultural
approach and contribute to the development of scientific and
technological excellence. Across the world, the Group enables its
customers and employees, and members of societies at large to live,
work and develop sustainably, in a safe and secure information
space.
Press contact
Constance Arnoux | constance.arnoux@atos.net |
+33 6 44 12 16 35
- PR - Atos opens Life Sciences Centre of Excellence to
accelerate drug development and enable precision health
solutions
Atos (EU:ATO)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Atos (EU:ATO)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024